Showing 241 - 260 results of 319 for search '"cervical cancer"', query time: 0.05s Refine Results
  1. 241

    Obesity and Cancer Screening according to Race and Gender by Heather Bittner Fagan, Richard Wender, Ronald E. Myers, Nicholas Petrelli

    Published 2011-01-01
    “…The relationship between obesity and cancer screening varies by screening test, race, and gender. Most studies on cervical cancer screening found a negative association between increasing weight and screening, and this negative association was most consistent in white women. …”
    Get full text
    Article
  2. 242

    Postcoital Bleeding: A Review on Etiology, Diagnosis, and Management by Christopher M. Tarney, Jasmine Han

    Published 2014-01-01
    “…However, the most serious cause of postcoital bleeding is cervical cancer. There are currently no recommendations from governing bodies such as the American College of Obstetricians and Gynecologists on evaluating and treating women with postcoital bleeding. …”
    Get full text
    Article
  3. 243

    Physician Satisfaction in a Cancer Prevention Program for Low-Income Women in Nevada by Christopher R. Cochran, Emmanuel C. Gorospe

    Published 2007-01-01
    “…In this pilot study, we explored physicians' needs and factors for satisfaction in the Women's Health Connection (WHC), a breast and cervical cancer-screening program for low-income women in Nevada. …”
    Get full text
    Article
  4. 244

    Synthesis of Polymer Assembled Mesoporous CaCO3 Nanoparticles for Molecular Targeting and pH-Responsive Controlled Drug Release by Jinjing Xing, Yeqiang Cai, Yikun Wang, Haifu Zheng, Yujia Liu

    Published 2020-01-01
    “…The cytotoxicity, targeting effect, and drug release of human cervical cancer cell line (HeLa) were studied by cell vitality and imaging experiments. …”
    Get full text
    Article
  5. 245

    Research Status of Clustered Regulary Interspaced Short Palindromic Repeats Technology in the Treatment of Human Papillomavirus (HPV) Infection Related Diseases by Minxue Tang MD

    Published 2025-01-01
    “…Its high specificity and low off-target effects make it exceptionally effective in applications involving Human Papillomavirus (HPV) related diseases, most notably cervical cancer. This approach offers a refined methodology for the rapid detection of viral infections and provides a robust platform for the safe and effective treatment of diseases associated with viral infections through gene therapy. …”
    Get full text
    Article
  6. 246

    Female genital schistosomiasis is a neglected public health problem in Tanzania: Evidence from a scoping review. by Gladys Mbwanji, Humphrey D Mazigo, Jane K Maganga, Jennifer A Downs

    Published 2024-03-01
    “…This review emphasizes integration of delivery of FGS related services in primary health care systems through the reproductive health clinics which covers sexually transmitted infections, HIV and cervical cancer screening. These actions are essential if this neglected gynecological disease is to be addressed in Tanzania.…”
    Get full text
    Article
  7. 247

    Clear Cell Carcinoma of the Endometrium Causing Paraneoplastic Retinopathy: Case Report and Review of the Literature by Paulina Cybulska, Eduardo V. Navajas, Filiberto Altomare, Marcus Q. Bernardini

    Published 2011-01-01
    “…Of these 28 cases, 14 patients were diagnosed with endometrial cancer, 7 with ovarian cancer, 5 with cervical cancer, 1 fallopian tube cancer and 1 with concomitant endometrial and ovarian cancers. …”
    Get full text
    Article
  8. 248

    Incisional Site Metastasis in a Patient with Cervical Carcinoma: A Case Report and Review of the Literature by C. Iavazzo, K. Madhuri, A. Tailor, S. Butler-Manuel

    Published 2012-01-01
    “…Moreover, we performed a literature search for abdominal wall metastases after radical hysterectomy for cervical cancer, and we present a table of the relative case reports. …”
    Get full text
    Article
  9. 249

    Parental Knowledge, Attitudes, and Behaviours towards Human Papillomavirus Vaccination for Their Children: A Systematic Review from 2001 to 2011 by Kristina Trim, Naushin Nagji, Laurie Elit, Katherine Roy

    Published 2012-01-01
    “…The percentage of parents who heard about HPV rose over time (from 60% in 2005 to 93% in 2009), as did their appreciation for the HPV infection and cervical cancer link (from 70% in 2003 to 91% in 2011). …”
    Get full text
    Article
  10. 250

    Distribution of pathologic smear results and histopathologic agreement in precancerous cervical lesions by Eser Colak, Esra Zeynep Coskunoglu

    Published 2020-12-01
    “… OBJECTIVES: The accuracy of the Papanicolau smear test is very important in cervical cancer which is preventable cancer. In this study, we aimed to investigate the distribution of smear results and cyto-histopathological correlation and agreement in biopsies. …”
    Get full text
    Article
  11. 251

    Women's experiences and acceptability of self-administered, home delivered, intravaginal 5-Fluorouracil cream for cervical precancer treatment in Kenya by Konyin Adewumi, Aparna Ghosh Kachoria, Everlyn Adoyo, Mercy Rop, Mercy Rop, Antony Owaya, Jennifer H. Tang, Jennifer H. Tang, Lisa Rahangdale, Lisa Rahangdale, Lisa Rahangdale, Chemtai Mungo, Chemtai Mungo, Chemtai Mungo

    Published 2025-02-01
    “…BackgroundInnovative strategies are essential to meet the World Health Organization's 90/70/90 cervical cancer elimination targets, aiming for 90% access to precancer treatment globally by 2030. …”
    Get full text
    Article
  12. 252

    Factors for Satisfaction Among Providers of Ancillary Health Services in a Community-Based Cancer Prevention Program: A Pilot Study in Nevada by Emmanuel C. Gorospe, Christopher R. Cochran, Elena E. Cabb

    Published 2006-01-01
    “…Assessment of the providers' factors for satisfaction in participating in cancer prevention programs can contribute to better services and can serve as a model for other community-based health programs.We conducted a pilot survey of providers of ancillary services in the Nevada Women's Health Connection, a community breast and cervical cancer prevention program. Of the 93 participating providers, a total of 44 providers completed the survey. …”
    Get full text
    Article
  13. 253

    Advances in Surface Plasmon Resonance-Based Biosensor Technologies for Cancer Cell Detection by Bhishma Karki, Arun Uniyal, Amrindra Pal, Vivek Srivastava

    Published 2022-01-01
    “…Using the finite element method-based simulation technique, the sensitivity obtained as 195.4 degree/RIU, 167.6 degree/RIU, 212.4 degree/RIU, 168.4 degree/RIU, 212.4 degree/RIU, 186.6 degree/RIU, 218.6 degree/RIU, 195.4 degree/RIU, 203.6 degree/RIU, 202.6 degree/RIU 203.6 degree/RIU, and 202.6 for basal (skin cancer), basal (normal cell), HeLa (cervical cancer), MCF-7 (breast cancer), HeLa (normal cell), Jurkat (blood cancer), Jurkat (normal cell), PCI-2 (adrenal gland cancer), PCI-2 (normal cell), MDA-MB-231 (breast cancer), MDA-MB-231 (normal cell), MCF-7 (breast cancer), and MCF-7 (normal cell), respectively, and other performance parameters such as detection accuracy, figure of merit, and full width and half maximum (FWHM) are also evaluated.…”
    Get full text
    Article
  14. 254

    Organoid development and applications in gynecological cancers: the new stage of tumor treatment by Yang Li, Meiying Qin, Ning Liu, Chunmei Zhang

    Published 2025-01-01
    “…Abstract Gynecologic cancers (GCs), including cervical cancer (CC), ovarian cancer (OC), endometrial cancer (EC), as well as vulvar and vaginal cancers, represent major health threats to women, with increasing incidence rates observed globally. …”
    Get full text
    Article
  15. 255

    Synthesis and Characterization of Iodinated Chitosan Nanoparticles and Their Effects on Cancer Cells by Germán Alvarado Tenorio, Roberto Espinosa Neira, Carlos Alberto Ávila Orta, Gabriela Yolotzín Romero Zúñiga, Hortensia Ortega Ortiz

    Published 2024-01-01
    “…The cytotoxic effects on human tumor cells of chitosan and iodine-modified chitosan nanoparticles (CSNPs-I and CSNPs-IO3) were evaluated for 24 h in a range from 0.15 mg/mL to 0.95 mg/mL concentrations, where CSNPs-IO3 presented the lower viability for lung cancer A549, followed by cervical cancer HeLa cell and finally breast cancer MDA-MB-231, with a weight content of iodate ion in a range of 8.7 to 15 μg. …”
    Get full text
    Article
  16. 256

    Endocervical adenocarcinomas and HPV genotyping in an HIV endemic milieu – a retrospective study by Lucília Lovane, Gabriella Lillsunde Larsson, Satish Tulsidás, Carla Carrilho, Sören Andersson, Christina Karlsson

    Published 2025-01-01
    “…Abstract Background Cervical cancer is the most prevalent cancer in Mozambique, with endocervical adenocarcinoma accounting for approximately 5.5% of cases. …”
    Get full text
    Article
  17. 257

    Cell Based Autologous Immune Enhancement Therapy (AIET) after Radiotherapy in a Locally Advanced Carcinoma of the Cervix by Sumana Premkumar, Vidyasagar Devaprasad Dedeepiya, Hiroshi Terunuma, Rajappa Senthilkumar, Thangavelu Srinivasan, Helen C. Reena, Senthilkumar Preethy, Samuel J. K. Abraham

    Published 2013-01-01
    “…As surgery is not acceptable by every patient and chemotherapy has associated side effects, we hereby report the positive outcome of in vitro expanded natural killer cell and activated T lymphocyte based autologous immune enhancement therapy (AIET) for the residual lymphadenopathy in a patient with locally advanced cervical cancer after radiation. After six transfusions of AIET, there was complete resolution of residual lymph nodes and there was no evidence of local lesion. …”
    Get full text
    Article
  18. 258

    Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries by Filip Tichanek, Asta Försti, Otto Hemminki, Akseli Hemminki, Kari Hemminki

    Published 2023-01-01
    “…Female cancers cover common breast cancers, relatively common endometrial, ovarian, and cervical cancers and rare vulvar cancer. Survival in these cancers is known to be relatively good compared to all cancers but long-term studies for these cancers are rare, and to fill the gap, here, we generate survival data through 50 years. …”
    Get full text
    Article
  19. 259

    Evaluation of Pathology Results of Patients with a History of Breast Cancer who were Operated on for Gynecological Pathologies or Prophylaxis by Necim Yalcin, Isin Ureyen, Aysun Alci, Mustafa Gokkaya, Alper Kahraman, Gorker Sel, Gulsum Ekin Sari, Tayfun Toptaş

    Published 2024-04-01
    “…Among these seven patients, four patients had malignant disease one patient had microinvasive cervical cancer, one patient had ovarian serous cancer, one patient had cervical and ovarian metastasis of breast cancer, and one patient had ovarian metastasis of breast cancer. …”
    Get full text
    Article
  20. 260

    Pathways and processes to adopting or switching to a single-dose HPV vaccination schedule in low- and middle-income countries: a qualitative study. by Sunny Roy, Megan D Wysong, Erica N Rosser, Ishani Sheth, Casey Geddes, Rupali J Limaye, Joseph G Rosen

    Published 2025-01-01
    “…The World Health Organization (WHO) recently endorsed a single-dose human papillomavirus vaccination (HPVV) schedule, but adoption of the revised immunization schedule has not been uniform, notably in low- and middle-income countries (LMICs) with outsized cervical cancer burdens. We sought to characterize the sequence of events, as well as actors/institutions involved, that facilitate or impede country-level decision-making related to the HPVV schedule. …”
    Get full text
    Article